Is Vectura Group a good dividend stock?

Vectura Group (LON:VEC) pays an annual dividend of GBX 38 per share and currently has a dividend yield of 23.06%. VEC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 189.05%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for VEC .

What other stocks do shareholders of Vectura Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vectura Group investors own include Hikma Pharmaceuticals (HIK) , SEB (SKP) , BTG (BTG) , iRobot (IRBT) , Sinclair Pharma (SPH) , Sirius Minerals (SXX) , Coats Group (COA) , Griffin Mining (GFM) , HSBC (HSBA) and Inmarsat (ISAT) .

How do I buy shares of Vectura Group?

Shares of VEC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:VEC

Vectura Group (VEC) Share Price, News & Analysis

→ REVEALED: Elon Musk’s Secret A.I. Facility? (From InvestorPlace) (Ad)

Free VEC Stock Alerts

Compare

Today's Range: N/A
50-Day Range: 164.80
▼
164.80
52-Week Range: N/A

Volume: 203,761 shs
Average Volume: 3.37 million shs
Market Capitalization: £1.01 billion

P/E Ratio: 8.20
Dividend Yield: 23.06%
Price Target: N/A

Stock Analysis

Get Vectura Group alerts:

Ad InvestorPlace

REVEALED: Elon Musk’s Secret A.I. Facility?

I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.

Click here to see the details because there’s a lot of money at stake.

About Vectura Group Stock (LON:VEC)

Vectura Group plc engages in the design, development, and supply of pharmaceutical products for the treatment of airways-related diseases worldwide. The company's in-market products include Seebri, Breezhaler and Neohaler, a DPI device and bronchodilator; AirFluSal Forspiro for the treatment of asthma and chronic obstructive pulmonary disease (COPD); Breelib for the treatment of pulmonary arterial hypertension; Relvar Ellipta/Breo Ellipta that is used in treating asthma and COPD; and Incruse Ellipta, Anoro Ellipta, and Trelegy Ellipta for the treatment of COPD. It is also developing VR315 (US) for the treatment of asthma and COPD.In addition, the company offers dry powder inhalers, pressurized metered dose inhalers, and nebulized devices. Vectura Group plc was founded in 1997 and is headquartered in Chippenham, the United Kingdom.

Ad InvestorPlace

REVEALED: Elon Musk’s Secret A.I. Facility?

I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.

Click here to see the details because there’s a lot of money at stake.

VEC Stock News Headlines

February 3, 2024 | finance.yahoo.com

Global Smart Inhalers Market to Surpass 51.85 Billion by 2030 Driven by Increasing Prevalence of Chronic Respiratory Diseases

January 16, 2024 | finance.yahoo.com

Philip Morris (PM) Poised Well on Pricing, Smoke-Free Strength

April 16, 2024 | InvestorPlace (Ad)

Forget Nvidia, buy this A.I. Stock Now

Forget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.

October 6, 2023 | lse.co.uk

VEC.L Regulatory News

September 20, 2023 | msn.com

Philip Morris (NYSE:PM) Mulls Stake Sale in Pharma Unit

September 20, 2023 | msn.com

Tobacco Giant Philip Morris Rethinks Pharma Dive, Mulls Vectura Stake Sale Amid Challenges: Report

September 20, 2023 | msn.com

Philip Morris evaluates selling stake in pharmaceuticals unit - report

September 4, 2023 | washingtonpost.com

Nestle’s Lessons From Joining the Dud Deals Club

April 16, 2024 | InvestorPlace (Ad)

Forget Nvidia, buy this A.I. Stock Now

July 24, 2023 | uk.investing.com

Monday newspaper round-up: Business energy, Vectura, Rhodes fire, Barbenheimer, interest rates

July 23, 2023 | thetimes.co.uk

Blow to PMI as top executives quit Vectura

July 22, 2023 | msn.com

CITY WHISPERS: Whiff of change in the air for cannabis firms

June 10, 2023 | forbes.com

Metro Group

June 1, 2023 | ft.com

PMI should forget wellness and focus on smokers who want to quit

May 17, 2023 | marketwatch.com

Ipratropium Bromide Market Forthcoming Trends and Share Analysis by 2031

May 8, 2023 | marketwatch.com

Latest "Ipratropium Bromide Market" Size Forecast 2023-2031: New Challenges, Drivers, and Restraints

May 3, 2023 | marketwatch.com

2023-2030 Targeted Drug Delivery System Market Size (Growth and Outlook) includes Latest Development | with [124 Pages]

April 30, 2023 | marketwatch.com

Nebulizers Market is poised to cross USD 1.9 billion by 2032

April 25, 2023 | marketwatch.com

Ipratropium Bromide Market Manufacturing Cost Structure By 2030

April 22, 2023 | marketwatch.com

2023-2030 Potassium Gluconate Market Size with [96 Pages] includes Market Restraints | New Report by Absolute Reports

April 3, 2023 | finance.yahoo.com

Aerami Therapeutics to Host Virtual Investor Day with Leading Experts in Pulmonary Hypertension as AER-901 (Inhaled Imatinib) Advances Toward Phase 2

March 28, 2023 | marketwatch.com

Polymers Drug Delivery Market Share and Forecast till 2031

March 28, 2023 | marketwatch.com

Ipratropium Bromide Market Share and Forecast till 2028

March 28, 2023 | marketwatch.com

Asthma and COPD Drugs Market Outlook and Forecast till 2031

March 27, 2023 | marketwatch.com

Oral Drug Delivery Market Growth and Forecast till 2031

March 24, 2023 | marketwatch.com

Medical Suction Catheters Market Size, Share, Growth | Global Report, 2031

March 22, 2023 | marketwatch.com

Bronchodilators Market Trends Business Opportunities, Segments and Industry Forecast By 2031

See More Headlines

Receive VEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vectura Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Drug Manufacturers - Major
Sub-Industry: N/A
Current Symbol: LON:VEC
CUSIP: N/A
CIK: N/A
Web: www.vectura.com
Phone: +44-1249-667700
Fax: N/A
Employees: 9,200
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 8.20
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 0.77
Current Ratio: 3.59
Quick Ratio: 3.20

Sales & Book Value

Annual Sales: £190.60 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 12.48
Book Value: GBX 91.70 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 613,892,000
Free Float: N/A
Market Cap: £1.01 billion
Optionable: Not Optionable
Beta: N/A

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. William Downie (Age 54)
CEO & Exec. Director
Comp: $538.92k
Mr. Paul Andrew Fry (Age 54)
CFO & Exec. Director
Comp: $807k
Mr. Anthony Fitzpatrick
Exec. VP of Operations
Dr. Geraldine Venthoye
Chief Scientific Officer & Exec. VP of Product Devel.
Elizabeth Knowles
VP of Investor Relations
Mr. John Murphy (Age 68)
Gen. Counsel & Company Sec.
David Ginivan
VP of Corp. Communications
Ms. Christina Olsen
Exec. VP of Corp. Strategy & Communications
Ms. Joanne Hombal (Age 47)
Exec. VP of HR
Mr. Roger Heerman (Age 48)
Exec. VP of Commercial & Bus. Devel.

Key Competitors

View All Competitors

VEC Stock Analysis - Frequently Asked Questions

Is Vectura Group a good dividend stock?: Vectura Group (LON:VEC) pays an annual dividend of GBX 38 per share and currently has a dividend yield of 23.06%. VEC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 189.05%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for VEC.
What other stocks do shareholders of Vectura Group own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Vectura Group investors own include Hikma Pharmaceuticals (HIK), SEB (SKP), BTG (BTG), iRobot (IRBT), Sinclair Pharma (SPH), Sirius Minerals (SXX), Coats Group (COA), Griffin Mining (GFM), HSBC (HSBA) and Inmarsat (ISAT).
How do I buy shares of Vectura Group?: Shares of VEC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:VEC) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Vectura Group (VEC) Share Price, News & Analysis

About Vectura Group Stock (LON:VEC)

VEC Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

VEC Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info